EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Native T1 Mapping and Clinical Risk Characterization in Non-Ischemic Dilated Cardiomyopathy: A Cardiac Magnetic Resonance Study

Manuela Montatore iD, Marco Rella iD, Eleonora Indolfi iD, Federica Masino iD, Ruggiero Tupputi, Eluisa Muscogiuri iD, Giuseppe Guglielmi iD

Journal of Cardiovascular Development and Disease · 19.06.2026 · 13 (6) · 279

DOI: 10.3390/jcdd13060279 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 19.06.2026. Verfasst von Manuela Montatore und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Medicine, School of Medicine, University of Foggia, 71122 Foggia, Italy. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Risk stratification in non-ischemic dilated cardiomyopathy (DCM) remains challenging because left ventricular ejection fraction (LVEF) and late gadolinium enhancement (LGE) do not fully capture the underlying myocardial substrate. Septal native T1 mapping provides a quantitative assessment of diffuse myocardial abnormalities and may contribute to myocardial tissue characterization within a multiparametric CMR framework.

Methods

This retrospective single-center study included 45 consecutive patients with non-ischemic DCM referred for clinically indicated CMR at Perrino Hospital, Brindisi, Italy, between November 2023 and November 2025. All examinations were performed using a standardized CMR protocol including cine imaging, LGE, and native T1 mapping on a 1.5-T Siemens Healthineers scanner. Septal native T1 was used as the primary mapping parameter because of its established reproducibility and robustness for myocardial tissue characterization. Patients were followed for a composite endpoint including all-cause mortality, major ventricular arrhythmic events, appropriate ICD therapy, and hospitalization for heart failure. Endpoint coding was verified, and all analyses were performed using the final validated dataset.

Results

During a median follow-up of 15 months, 14 patients (31.1%) experienced the composite endpoint. Patients with events had lower LVEF (27.1 ± 7.8% vs. 48.3 ± 10.5%; p < 0.001), higher LVEDVi (142.6 ± 28.5 vs. 110.6 ± 23.4 mL/m2; p = 0.001), and higher septal native T1 values among patients with available T1 measurements (1047.5 ± 25.0 vs. 1031.5 ± 24.3 ms; p = 0.065). ROC analysis identified a septal native T1 threshold of 1042 ms for prediction of the composite endpoint, with an exploratory AUC of 0.70. Event-free survival was lower in patients with septal native T1 ≥ 1042 ms. Given the limited number of events, all regression and hierarchical analyses should be interpreted as exploratory and hypothesis-generating.

Conclusions

Higher septal native T1 values were observed in patients experiencing adverse clinical outcomes; however, native T1 was not independently associated with the composite endpoint in exploratory Cox regression analyses.

Schlagwörter

Stichwörter der Autor:innen

cardiac magnetic resonancedilated cardiomyopathylate gadolinium enhancementmyocardial fibrosisnative T1 mappingprognosisrisk stratification

Autor:innen und Institutionen

  • Department of Clinical and Experimental Medicine, School of Medicine, University of Foggia, 71122 Foggia, Italy.
  • Radiology Unit, "A. Perrino" Hospital, ASL Brindisi, 72100 Brindisi, Italy.
  • Cardiology Unit, "D. Camberlingo" Hospital, ASL Brindisi, 72021 Francavilla Fontana, Italy.
  • Radiology Unit, "Dimiccoli" Hospital, Viale Ippocrate 15, 70051 Barletta, Italy.

ORCID-Profile: Manuela Montatore, Marco Rella, Eleonora Indolfi, Federica Masino, Eluisa Muscogiuri, Giuseppe Guglielmi

Zitieren

APA

Montatore, M., Rella, M., Indolfi, E., Masino, F., Tupputi, R., Muscogiuri, E., & Guglielmi, G. (2026). Native T1 Mapping and Clinical Risk Characterization in Non-Ischemic Dilated Cardiomyopathy: A Cardiac Magnetic Resonance Study. Journal of Cardiovascular Development and Disease, 13(6), 279. https://doi.org/10.3390/jcdd13060279

Vancouver

Montatore M, Rella M, Indolfi E, Masino F, Tupputi R, Muscogiuri E, et al. Native T1 Mapping and Clinical Risk Characterization in Non-Ischemic Dilated Cardiomyopathy: A Cardiac Magnetic Resonance Study. Journal of Cardiovascular Development and Disease. 2026;13(6):279. doi:10.3390/jcdd13060279

BibTeX
@article{Montatore2026,
  author = {Montatore, Manuela and Rella, Marco and Indolfi, Eleonora and Masino, Federica and Tupputi, Ruggiero and Muscogiuri, Eluisa and Guglielmi, Giuseppe},
  title = {Native T1 Mapping and Clinical Risk Characterization in Non-Ischemic Dilated Cardiomyopathy: A Cardiac Magnetic Resonance Study},
  journal = {Journal of Cardiovascular Development and Disease},
  year = {2026},
  volume = {13},
  number = {6},
  pages = {279},
  doi = {10.3390/jcdd13060279}
}
Kostenlos starten →